NO954287L - Anvendelse av indolderivater som 5-HT1 agonister - Google Patents

Anvendelse av indolderivater som 5-HT1 agonister

Info

Publication number
NO954287L
NO954287L NO954287A NO954287A NO954287L NO 954287 L NO954287 L NO 954287L NO 954287 A NO954287 A NO 954287A NO 954287 A NO954287 A NO 954287A NO 954287 L NO954287 L NO 954287L
Authority
NO
Norway
Prior art keywords
agonists
indole derivatives
indole
derivatives
Prior art date
Application number
NO954287A
Other languages
English (en)
Other versions
NO308236B1 (no
NO954287D0 (no
Inventor
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO954287L publication Critical patent/NO954287L/no
Publication of NO954287D0 publication Critical patent/NO954287D0/no
Publication of NO308236B1 publication Critical patent/NO308236B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO954287A 1993-04-27 1995-10-26 Farmasøytisk blanding inneholdende indolderivater NO308236B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5393093A 1993-04-27 1993-04-27
PCT/IB1994/000079 WO1994025023A1 (en) 1993-04-27 1994-04-26 Use of indole derivatives as 5ht1 antagonists

Publications (3)

Publication Number Publication Date
NO954287L true NO954287L (no) 1995-10-26
NO954287D0 NO954287D0 (no) 1995-10-26
NO308236B1 NO308236B1 (no) 2000-08-21

Family

ID=21987528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954287A NO308236B1 (no) 1993-04-27 1995-10-26 Farmasøytisk blanding inneholdende indolderivater

Country Status (29)

Country Link
EP (1) EP0696194B1 (no)
JP (1) JP2922307B2 (no)
KR (1) KR960701636A (no)
CN (3) CN1515252A (no)
AP (1) AP486A (no)
AT (1) ATE222492T1 (no)
AU (1) AU689469B2 (no)
BG (1) BG61898B1 (no)
BR (1) BR9406435A (no)
CA (1) CA2161533C (no)
CO (1) CO4230093A1 (no)
CZ (1) CZ290416B6 (no)
DE (1) DE69431201T2 (no)
DK (1) DK0696194T3 (no)
ES (1) ES2180573T3 (no)
HU (1) HU222488B1 (no)
IL (1) IL109376A (no)
MX (1) MX9403088A (no)
NO (1) NO308236B1 (no)
NZ (1) NZ263614A (no)
OA (1) OA10189A (no)
PL (1) PL175156B1 (no)
PT (1) PT696194E (no)
RO (1) RO117760B1 (no)
RU (1) RU2132683C1 (no)
SG (1) SG43951A1 (no)
SK (1) SK283353B6 (no)
WO (1) WO1994025023A1 (no)
ZA (1) ZA942805B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
CA2169179C (en) * 1993-08-31 2000-02-29 John E. Macor 5-arylindole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
ATE224388T1 (de) * 1994-10-12 2002-10-15 Pfizer Res & Dev Indolderivate zur behandlung von migräne
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
CA3166940A1 (en) * 2020-02-04 2021-08-12 Abdelmalik Slassi 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9106978A (pt) * 1990-10-15 1993-09-28 Pfizer Derivados de indol
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CZ290416B6 (cs) 2002-07-17
DK0696194T3 (da) 2002-10-07
CA2161533A1 (en) 1994-11-10
HU9503089D0 (en) 1995-12-28
EP0696194A1 (en) 1996-02-14
CN1515252A (zh) 2004-07-28
DE69431201D1 (de) 2002-09-26
ATE222492T1 (de) 2002-09-15
ES2180573T3 (es) 2003-02-16
NZ263614A (en) 1998-02-26
SK283353B6 (sk) 2003-06-03
WO1994025023A1 (en) 1994-11-10
HU222488B1 (hu) 2003-07-28
CN1509713A (zh) 2004-07-07
RO117760B1 (ro) 2002-07-30
JPH08504829A (ja) 1996-05-28
NO308236B1 (no) 2000-08-21
RU2132683C1 (ru) 1999-07-10
BG100093A (bg) 1996-04-30
OA10189A (en) 1996-12-18
BR9406435A (pt) 1996-01-09
IL109376A0 (en) 1994-07-31
EP0696194B1 (en) 2002-08-21
PL311266A1 (en) 1996-02-05
CO4230093A1 (es) 1995-10-19
AP486A (en) 1996-04-16
KR960701636A (ko) 1996-03-28
PT696194E (pt) 2002-11-29
AP9400633A0 (en) 1994-04-30
CZ9502802A3 (en) 1996-04-17
CN1121689A (zh) 1996-05-01
CA2161533C (en) 1998-08-04
DE69431201T2 (de) 2002-12-05
BG61898B1 (bg) 1998-09-30
PL175156B1 (pl) 1998-11-30
IL109376A (en) 2000-10-31
SK133295A3 (en) 1997-01-08
MX9403088A (es) 1997-02-28
SG43951A1 (en) 1997-11-14
AU6436094A (en) 1994-11-21
ZA942805B (en) 1995-10-23
JP2922307B2 (ja) 1999-07-19
HUT73670A (en) 1996-09-30
NO954287D0 (no) 1995-10-26
AU689469B2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
NO934800L (no) Anvendelse av tetrahydrokarbazonderivater som 5HT1-reseptoragonister
KR950700906A (ko) 5-ht1 작동약으로서의 인돌 유도체(indole derivatives as 5-ht1 agonists)
FI944805A (fi) Indolijohdannaisia 5-HT1-kaltaisina agonisteina
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
FI970310A0 (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
FI962969A (fi) Indolijohdannaisia 5-HT1:n agonisteina
NO954287L (no) Anvendelse av indolderivater som 5-HT1 agonister
NO984727L (no) Substituert benzensulfonamid derivater som promedikamenter av COX-2 inhibitorer
NO980467D0 (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO902933L (no) Fremgangsmaate for fremstilling av 2-(aminoaryl)indoler ogindoliner samt anvendelse som medikamenter.
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO974043L (no) Indolderivater som EAA-antagonister
NO962364D0 (no) N-akyl-2 arylcycloalkylmetylaminderivater som melatonerge midler
NO985970L (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
DE69320653D1 (de) Tetrahydrocarbazolderivate als 5-ht1-ähnliche agonisten
ATE193701T1 (de) Substituierte indol-derivate
DK0944601T3 (da) Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
NO965165D0 (no) Anvendelse av 8,9-dehydroestron som en antioksydant

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees